Keith Myers - LHC Co-Founder, Chairman and CEO

LHCGDelisted Stock  USD 169.81  0.00  0.00%   

Chairman

Mr. Keith G. Myers is the Chairman of the Board and Chief Executive Officer of LHC Group, Inc. Mr. Myers served as our President from 1994 to 1997, and again assumed the role as President from August 2009 to November 2010. Prior to founding the company, Mr. Myers founded, coowned and operated Louisiana Premium Seafoods, Inc., an international food processing, procurement, and distribution company. In 1999, Mr. Myers was named Business Executive of the Year by the Louisiana Rural Health Association. Mr. Myers received credentials from the National Association for Home Care Hospice in 1999 and was granted credentials by the Healthcare Financial Management Association in 2005. Mr. Myers was an active participant in the Home Health Top 100 since 2002 and has participated in the preparation of numerous white papers and presentations to members of both the U.S. Senate and House of Representatives, specifically related to health care reimbursement methodologies. In June 2003, Mr. Myers was named the Regional Entrepreneur of the Year for outstanding performance in the field of Health Services and was officially inducted as a lifetime member of The Ernst Young National Entrepreneur of the Year Hall of Fame in November 2003. We believe that Mr. Myerss extensive experience in the home care industry, combined with his leadership role as our Chief Executive Officer, provides great value to the ability of our Board of Directors to establish and oversee our strategic initiatives. since 2010.
Age 64
Tenure 14 years
Phone337 233 1307
Webhttps://www.lhcgroup.com

LHC Management Efficiency

The company has return on total asset (ROA) of 0.0312 % which means that it generated a profit of $0.0312 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0486 %, meaning that it created $0.0486 on every $100 dollars invested by stockholders. LHC's management efficiency ratios could be used to measure how well LHC manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 661.2 M in liabilities with Debt to Equity (D/E) ratio of 0.52, which is about average as compared to similar companies. LHC Group has a current ratio of 1.34, which is within standard range for the sector. Debt can assist LHC until it has trouble settling it off, either with new capital or with free cash flow. So, LHC's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like LHC Group sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for LHC to invest in growth at high rates of return. When we think about LHC's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 11 records

CHAIRMAN Age

Eric LloydBarings BDC
54
Sigurd ThorvildsenAwilco Drilling PLC
50
Eric ColsonArtisan Partners Asset
51
Philip GingerichJuniata Valley Financial
58
Michael FrenoBarings BDC
43
Lawrence WeinbachDiscover Financial Services
78
Timothy HaviceJuniata Valley Financial
69
Andrew ZieglerArtisan Partners Asset
62
Lazaro BrandaoBarings BDC
88
Thomas MaherasDiscover Financial Services
58
Antonio BorniaBarings BDC
78
LHC Group, Inc., a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. The company was founded in 1994 and is based in Lafayette, Louisiana. LHC operates under Medical Care Facilities classification in the United States and is traded on NASDAQ Exchange. It employs 29000 people. LHC Group (LHCG) is traded on NASDAQ Exchange in USA and employs 29,000 people.

Management Performance

LHC Group Leadership Team

Elected by the shareholders, the LHC's board of directors comprises two types of representatives: LHC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of LHC. The board's role is to monitor LHC's management team and ensure that shareholders' interests are well served. LHC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, LHC's outside directors are responsible for providing unbiased perspectives on the board's policies.
Tyree Wilburn, Independent Director
Donald Stelly, Pres and COO
Eric Elliott, Vice President of Investor Relations
Tricia Nguyen, Executive Vice President Chief Medical Officer
Jonathan Goldberg, Independent Director
Mohammad Ali, Chief Officer
Kenneth Thorpe, Independent Director
Teri Fontenot, Independent Director
Clifford Holtz, Independent Director
Bruce Greenstein, Executive Vice President Chief Strategy and Innovation Officer
Ronald Nixon, Independent Director
Nicholas III, Exec Counsel
JoAnne Little, VP Officer
John Breaux, Independent Director
Wilbert Tauzin, Lead Independent Director
Rexanne Domico, Senior Vice President - Home Care and Hospice Operations
Brent Turner, Director
Christopher Shackelton, Independent Director
Steven Guenthner, Executive Vice President Chief Strategy Officer
Earl Reed, Independent Director
John Indest, Consultant, Director and Chairman of Clinical Quality Committee
Marcus Macip, Exec Officer
Nicholas Gachassin, Executive Vice President General Counsel
Monica Azare, Independent Director
Kimberly Seymour, VP Officer
MS BS, Ex Officer
Dan Wilford, Independent Director
Dionne Viator, CFO, Executive Vice President Treasurer
Keith Myers, Co-Founder, Chairman and CEO
W Tauzin, Lead Independent Director
Joshua Proffitt, Chief Legal Officer, Executive VP of Acquisitions and Strategic Partnerships, General Counsel and Corporate Secretary
Dale Mackel, CFO VP
George Lewis, Independent Director

LHC Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is LHC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LHC in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LHC's short interest history, or implied volatility extrapolated from LHC options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
Note that the LHC Group information on this page should be used as a complementary analysis to other LHC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Other Consideration for investing in LHC Stock

If you are still planning to invest in LHC Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LHC's history and understand the potential risks before investing.
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Bonds Directory
Find actively traded corporate debentures issued by US companies
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Stocks Directory
Find actively traded stocks across global markets
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world